Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lavinia Vija

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Nuclear Medicine Communications|July 19, 2017
Clinical outcomes 1 year after empiric 131I therapy for hyperthyroid disorders: real life experience and predictive factors of functional responseLavinia Vija Racaru, Charlotte Fontan, Mathilde Bauriaud-Mallet, et al.
American Journal of Clinical Oncology|July 12, 2012
Additional diagnostic value of hybrid SPECT-CT systems imaging in patients with differentiated thyroid cancerMarie-Elisabeth Toubert, Lavinia Vija, Laetitia Vercellino, et al.
Molecular and Cellular Endocrinology|May 28, 2013
Expression and characterization of androgen receptor coregulators, SRC-2 and HBO1, during human testis ontogenesis and in androgen signaling deficient patientsLavinia Vija, Geri Meduri, Eva Comperat, et al.
Advances in Experimental Medicine and Biology|November 30, 2023
The Cholesterol-5,6-Epoxide Hydrolase: A Metabolic Checkpoint in Several DiseasesPhilippe de Medina, Silia Ayadi, Khadijetou Diallo, et al.
EJNMMI Physics|January 22, 2024
Insertion of synthetic lesions on patient data: a method for evaluating clinical performance differences between PET systemsQuentin Maronnier, Nesrine Robaine, Léonor Chaltiel, et al.
Nuclear Medicine Communications|May 24, 2018
Fluorine-18-fluorocholine PET/CT parameters predictive for hematological toxicity to radium-223 therapy in castrate-resistant prostate cancer patients with bone metastases: a pilot studyLavinia Vija Racaru, Mathieu Sinigaglia, Salim Kanoun, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 20, 2025
Prognostic impact of metabolic tumor volume using the SUV4.0 segmentation threshold in 1,960 lymphoma patients from prospective LYSA trialsSolène Malmon, Mad-Helenie Elsensohn, Catherine Thieblemont, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 10, 2023
Normal organ dosimetry for thyroid cancer patients treated with radioiodine as part of the multi-centre multi-national Horizon 2020 MEDIRAD projectJan Taprogge, Alex Vergara-Gil, Francesca Leek, et al.
European Thyroid Journal|June 18, 2025
Predictive factors of radioiodine ablation success: results from a MEDIRAD prospective clinical study for thyroid cancerJan Taprogge, Iain Murray, Hannah Sharman, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Nuclear Medicine Communications|July 19, 2017
Clinical outcomes 1 year after empiric 131I therapy for hyperthyroid disorders: real life experience and predictive factors of functional responseLavinia Vija Racaru, Charlotte Fontan, Mathilde Bauriaud-Mallet, et al.
American Journal of Clinical Oncology|July 12, 2012
Additional diagnostic value of hybrid SPECT-CT systems imaging in patients with differentiated thyroid cancerMarie-Elisabeth Toubert, Lavinia Vija, Laetitia Vercellino, et al.
Molecular and Cellular Endocrinology|May 28, 2013
Expression and characterization of androgen receptor coregulators, SRC-2 and HBO1, during human testis ontogenesis and in androgen signaling deficient patientsLavinia Vija, Geri Meduri, Eva Comperat, et al.
Advances in Experimental Medicine and Biology|November 30, 2023
The Cholesterol-5,6-Epoxide Hydrolase: A Metabolic Checkpoint in Several DiseasesPhilippe de Medina, Silia Ayadi, Khadijetou Diallo, et al.
EJNMMI Physics|January 22, 2024
Insertion of synthetic lesions on patient data: a method for evaluating clinical performance differences between PET systemsQuentin Maronnier, Nesrine Robaine, Léonor Chaltiel, et al.
Nuclear Medicine Communications|May 24, 2018
Fluorine-18-fluorocholine PET/CT parameters predictive for hematological toxicity to radium-223 therapy in castrate-resistant prostate cancer patients with bone metastases: a pilot studyLavinia Vija Racaru, Mathieu Sinigaglia, Salim Kanoun, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 20, 2025
Prognostic impact of metabolic tumor volume using the SUV4.0 segmentation threshold in 1,960 lymphoma patients from prospective LYSA trialsSolène Malmon, Mad-Helenie Elsensohn, Catherine Thieblemont, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 10, 2023
Normal organ dosimetry for thyroid cancer patients treated with radioiodine as part of the multi-centre multi-national Horizon 2020 MEDIRAD projectJan Taprogge, Alex Vergara-Gil, Francesca Leek, et al.
European Thyroid Journal|June 18, 2025
Predictive factors of radioiodine ablation success: results from a MEDIRAD prospective clinical study for thyroid cancerJan Taprogge, Iain Murray, Hannah Sharman, et al.
Pageof 3